46. Malignant rheumatoid arthritis Clinical trials / Disease details

Clinical trials : 4,356 /  Drugs : 2,567 - (DrugBank : 415) / Drug target genes : 192 - Drug target pathways : 228

  
2 trials found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT05718583
(ClinicalTrials.gov)		February 1, 202330/1/2023Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate RespondersA Pilot Proof of Concept Study of the Effects of Administration of a Short Chain Fatty Acid (SCFA) Supplement in Rheumatoid Arthritis Inadequate Responders (EASi-RAIR)Rheumatoid ArthritisDietary Supplement: ButyrateNYU Langone HealthArthritis FoundationRecruiting18 YearsN/AAll35N/AUnited States
2NCT05576597
(ClinicalTrials.gov)		August 23, 20227/10/2022Effect of Butyrate Supplement on Rheumatoid ArthritisA Pilot Study to Evaluate Efficacy and Safety of Butyrate Supplement in the Treatment of Rheumatoid ArthritisRheumatoid ArthritisDrug: Sodium ButyratePeking University People's HospitalNULLRecruiting18 YearsN/AAll30Phase 2China